CARBOMEDICS STANDARD A5-016Recalls & reported problems
Corcym Srl · Class 3 · Implant
All models of CARBOMEDICS STANDARD (12)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 08022057012586), received between Nov 22, 2018 and Mar 24, 2023 — classified as 2 injuries, 1 malfunction.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem3
Patient problems
- Aortic Valve Insufficiency/ Regurgitation2
- No Information1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryMar 24, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE MANUFACTURER WAS INFORMED OF THE FOLLOWING EVENT THROUGH DEVICE TRACKING DATABASE. IN THE PATIENT REGISTRATION FORM, IT WAS INDICATED THAT A CARBOMEDICS STANDARD PROSTHETIC AORTIC HEART VALVE, A5-016 WAS ''DISPOSED'' ON 18 AUG 2020. BASED ON THE OPERATIONAL REPORT RECEIVED, AFTER SEVERAL ATTEMPTS TO REPAIR THE LEFT AV VALVE, IT WAS DECIDED THAT THE ORIFICE WAS ALWAYS GOING TO BE TOO SMALL, AND BECAUSE THERE WAS AN EXTENSION OF THE VALVULAR TISSUE WHERE THE COMMISSURE BETWEEN THE SUPERIOR BRIDGING LEAFLET AND MURAL LEAFLET SHOULD HAVE BEEN, IT WAS ELECTED TO REPLACE THE VALVE ON THE LEFT SIDE BECAUSE IT FELT THIS WOULD BE THE ONLY WAY TO ACHIEVE AN ADEQUATE INFLOW, WHICH WOULD REMAIN COMPETENT. THE VALVE WAS EXCISED, AND THEY WERE ABLE TO IMPLANT A 16 MM CARBOMEDICS AORTIC PROSTHESIS IN INVERTED POSITION USING 5-0 PROLENE INTERRUPTED MATTRESS SUTURES. THE VALVE APPEARED TO BE SEATED VERY NICELY, AND BOTH LEAFLETS MOVED FREELY. THE HEART WAS ATTEMPTED TO WEAN FROM BYPASS. THE HEART WAS POOR OFF BYPASS WITH MAINTAINED FUNCTION, BUT POOR CARDIAC OUTPUT. A TRANSESOPHAGEAL ECHOCARDIOGRAM WAS OBTAINED. DURING REWARMING, THE VALVE WAS SEEN TO BE OPENING AND CLOSING IN A SYMMETRICAL FA
Patient problems: Aortic Valve Insufficiency/ Regurgitation
MAUDE report 16616503 ↗InjuryMar 24, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE MANUFACTURER WAS INFORMED OF THE FOLLOWING EVENT THROUGH DEVICE TRACKING DATABASE. IN THE PATIENT REGISTRATION FORM, IT WAS INDICATED THAT A CARBOMEDICS STANDARD PROSTHETIC AORTIC HEART VALVE, A5-016 WAS ''DISPOSED'' ON (B)(6) 2020. BASED ON THE OPERATIONAL REPORT RECEIVED, AFTER SEVERAL ATTEMPTS TO REPAIR THE LEFT AV VALVE, IT WAS DECIDED THAT THE ORIFICE WAS ALWAYS GOING TO BE TOO SMALL, AND BECAUSE THERE WAS AN EXTENSION OF THE VALVULAR TISSUE WHERE THE COMMISSURE BETWEEN THE SUPERIOR BRIDGING LEAFLET AND MURAL LEAFLET SHOULD HAVE BEEN, IT WAS ELECTED TO REPLACE THE VALVE ON THE LEFT SIDE BECAUSE IT FELT THIS WOULD BE THE ONLY WAY TO ACHIEVE AN ADEQUATE INFLOW, WHICH WOULD REMAIN COMPETENT. THE VALVE WAS EXCISED, AND THEY WERE ABLE TO IMPLANT A 16 MM CARBOMEDICS AORTIC PROSTHESIS IN INVERTED POSITION USING 5-0 PROLENE INTERRUPTED MATTRESS SUTURES. THE VALVE APPEARED TO BE SEATED VERY NICELY, AND BOTH LEAFLETS MOVED FREELY. THE HEART WAS ATTEMPTED TO WEAN FROM BYPASS. THE HEART WAS POOR OFF BYPASS WITH MAINTAINED FUNCTION, BUT POOR CARDIAC OUTPUT. A TRANSESOPHAGEAL ECHOCARDIOGRAM WAS OBTAINED. DURING REWARMING, THE VALVE WAS SEEN TO BE OPENING AND CLOSING IN A SYMMETRICAL FA
Patient problems: Aortic Valve Insufficiency/ Regurgitation
MAUDE report 16616386 ↗MalfunctionNov 22, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ON (B)(6) 2018 A PATIENT RECEIVED A CARBOMEDICS STANDARD A5-016 MECHANICAL HEART VALVE IMPLANT. DURING THE POST-OPERATIVE ECHOCARDIOGRAPHY THE SITE NOTICED A LEAKAGE. THE VALVE WAS EXPLANTED AND REPLACED WITH A R5-019 CARBOMEDICS REDUCED AORTIC VALVE ON (B)(6) 2018.
Patient problems: No Information
MAUDE report 8098901 ↗
Other HEART-VALVE, MECHANICAL devices
- On-X Mitral Heart Valve with Conform-X Sewing Ring ONXMC-25/33On-X Life Technologies, Inc. · Heart-Valve, Mechanical1 recall1 death34 reports
- SJM Regent™ AGFN-756St. Jude Medical, Inc. · HEART-VALVE, MECHANICAL3 deaths70 reports
- SJM Regent™ AGFN-756St. Jude Medical, Inc. · HEART-VALVE, MECHANICAL5 deaths66 reports
- SJM Regent™ 23AGFN-756St. Jude Medical, Inc. · HEART-VALVE, MECHANICAL3 deaths44 reports
- CARBOMEDICS SUPRA-ANNULAR (TOP HAT) S5-021Corcym Srl · HEART-VALVE, MECHANICAL7 deaths37 reports
- Regent™ 21AGFN-756St. Jude Medical, Inc. · HEART-VALVE, MECHANICAL3 deaths35 reports
- Regent™ 23AGFN-756St. Jude Medical, Inc. · HEART-VALVE, MECHANICAL2 deaths33 reports
- Regent™ 19AGFN-756St. Jude Medical, Inc. · HEART-VALVE, MECHANICAL31 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page